RecruitingNCT07143110

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada


Sponsor

AstraZeneca

Enrollment

60,000 participants

Start Date

Aug 20, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.


Eligibility

Min Age: 18 YearsMax Age: 130 Years

Plain Language Summary

Simplified for easier understanding

This study is a real-world analysis using existing health records to understand how lung cancer is treated in Canada and what it costs the healthcare system. Researchers are not recruiting participants in the traditional sense — instead, they are analyzing data from health insurance databases. **You may be eligible if...** - You were diagnosed with lung cancer between January 1, 2018 and the end of the study period - You were 18 years or older at the time of diagnosis - You had at least 12 months of health insurance coverage before your diagnosis - You were a resident of Ontario or Alberta at the time of diagnosis **You may NOT be eligible if...** - You were diagnosed with another cancer in the 5 years before January 2018 - You were diagnosed with another cancer at the same time as your lung cancer - Your records are incomplete or missing key information - You were not a resident of Ontario or Alberta at diagnosis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Research Site

Calgary, Alberta, Canada

Research Site

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07143110


Related Trials